Assam Tea and Health
Assam tea and health, sorted by how strong the evidence is: what the chemistry of the cup actually measures out to, what the human trials and cohorts support, what the FDA and EFSA have and have not signed off, what milk does, where the ceilings sit, and what the health record looks like in the gardens themselves.
On this page
The health record of Assam tea has two halves: what a strong, fully oxidised, milk-taking black tea does inside the person drinking it, and what the health record looks like in the gardens that grow it.
The chemistry of the cup
Black tea is a manufactured product, and the manufacture is the point. Fresh leaf is loaded with catechins, the small flavan-3-ol molecules most of the world's tea health research was built on, and rolling breaks the leaf's cells and puts its own polyphenol oxidase to work on them. A review of the enzymology in Molecules puts the scale plainly: about 75 percent of the catechins in the leaf1 are oxidised and polymerised into secondary polyphenols, chiefly theaflavins and thearubigins, with theasinensins, theacitrins and oolongtheanins alongside.
Assam pushes that further than most origins, because most Assam is CTC. A 2026 survey in Foods of 32 finished Assam black teas from Upper Assam and the North Bank, run under ISO protocols, states that during CTC processing catechin levels fall by about 96 percent2, and in the CTC samples the measured content ran from below detectable limit to low concentrations. Orthodox is different: the same survey still found EGCG at 0.86 to 12.34 mg/g and ECG at 2.10 to 13.35 mg/g. Every sample in the set met the ISO and FSSAI minimums.
| Fraction | Range across the 32 teas | Average |
|---|---|---|
| Total polyphenols | 83.54 to 184.52 mg/g | 134.07 mg/g |
| Thearubigins | 59.62 to 145.37 mg/g | 114.49 mg/g |
| Theaflavins | 4.88 to 15.54 mg/g | 8.61 mg/g |
| Caffeine | 15.51 to 39.24 mg/g | 30.09 mg/g |
| Theanine | 2.47 to 8.16 mg/g | 5.53 mg/g |
| Monomeric catechins, orthodox | EGCG 0.86 to 12.34, ECG 2.10 to 13.35 mg/g | measurable |
| Monomeric catechins, CTC | below detectable limit to low concentrations | very low |
They are converted, and the total stays high. What changes is which molecules you hold: the compound most of the tea health literature is about is the one a cup of CTC Assam has least of.
The converted fraction is also the less studied one. The Molecules review puts thearubigins at about 20 percent of extracted solids in one passage and up to 60 percent of the dry weight of black tea extract in another, and states that their chemistry is still unclear.
What the human evidence supports
Three bodies of evidence carry real weight. None is about Assam; all are about black tea or tea in general.
The first is a formal guideline. In 2022 a panel working under the Academy of Nutrition and Dietetics and the GRADE framework published the first dietary bioactive guideline for flavan-3-ols, from a review of 157 randomised controlled trials and 15 cohort studies. It suggests that consuming 400 to 600 mg per day of flavan-3-ols can reduce risk associated with cardiovascular disease and diabetes3, from foods low in added sugars, tea among them.
"We suggest" is GRADE's language for a conditional recommendation. Only 48 of the 157 trials were of good methodological quality. Every vascular outcome was assigned low quality evidence except systolic blood pressure, which got moderate. Its own table of food sources ranks brewed black tea second, behind green tea, at 277.32 mg against 318.74 mg per 8-ounce serving.
The second is blood pressure, where three meta-analyses land in the same narrow place. A 2014 pooled analysis of 11 studies and 378 subjects drinking four to five cups daily found systolic pressure lower by 1.8 mmHg and diastolic by 1.3 mmHg4, and discloses that Unilever R&D Vlaardingen funded the review and employs four of its authors. Two independent analyses sit at the low end of the same range: a 2014 British Journal of Nutrition black tea subgroup at 1.4 mmHg systolic and 1.1 diastolic14, and a 2021 Food and Function analysis at 1.04 and 0.5915. Acute intake did nothing. Regular drinking shifts systolic pressure by roughly 1 to 2 mmHg, the largest estimate is the industry-funded one.
The third is mortality, the closest thing to a black tea study at scale. The UK Biobank cohort followed 498,043 adults aged 40 to 695 for a median 11.2 years, recording 29,783 deaths, and 89 percent of its tea drinkers drank black tea. Against non-drinkers the all-cause hazard ratio, the death rate in one group as a fraction of another's over the follow-up, was 0.95 at one cup or fewer and 0.87 at two to three cups, then 0.88 from four through seven, 0.91 at eight to nine and 0.89 at ten or more. The benefit arrives at two cups a day and then flattens, and ten cups is no better than two.
A meta-analysis of 38 prospective cohort data sets covering 1,956,549 participants6, the UK Biobank among them, found the same shape: greatest reduction at 2.0 cups a day and none above it. It could not test black tea separately, since most of its studies did not report results by tea type, and called for more large cohorts. The Biobank authors state their own limits: portion size and tea strength were never assessed, and intake was recorded once, at baseline.
What regulators have signed, and what they have not
| Body | Subject | Position |
|---|---|---|
| FDA | Black tea, any health claim | No entry on either list. None permitted, none even denied. |
| FDA | Green tea and breast and prostate cancer | Qualified health claim under enforcement discretion, 24 February 2011, updated 17 April 2012. |
| FDA | Green tea and nine named cancers plus total cancers | Denied, 30 June 2005. |
| FDA | Green tea and cardiovascular disease | Denied, 9 May 2006. |
| EFSA NDA Panel | Black tea and improvement of attention | Favourable scientific opinion, 2018. Effect attributed to caffeine. |
No qualified health claim of any kind exists for black tea in the United States. The only tea claims the FDA has allowed to stand7 concern green tea and the risk of breast and prostate cancer, and green tea and cardiovascular disease was refused outright in 20068.
In 2018 the EFSA NDA Panel, on an application from Unilever, concluded that a cause and effect relationship has been established between the consumption of black tea and improvement of attention9, with the wording "owing to its caffeine content, black tea improves attention," conditional on two to three servings providing at least 75 mg of caffeine in total within 90 minutes.
The applicant had argued for a synergy between caffeine and L-theanine. The Panel rejected that framing: the effect can be explained by the caffeine. So the favourable opinion black tea holds in Europe is, on the Panel's own reasoning, an opinion about caffeine. EFSA issued a scientific opinion, which is not the same act as the European Commission entering a claim in the EU register.
What milk does, and what it does not
Why the two fit, casein binding the tannin that would otherwise pucker, is set out at milk and Assam, which holds the absorption half of the health answer below. The contest resolves along a line between two different things being measured: whether the polyphenols get into you, and whether they do anything once there.
Absorption studies mostly find nothing. Three small crossovers, all with Unilever involvement, found that adding milk changed neither blood catechin levels16 in 12 volunteers in 1998, nor plasma antioxidant activity17 in 21 in 2000, nor flavonol bioavailability18 in 18 in 2001. An independent Indian study in 2005 found the area under the curve for plasma catechins lower with milk, and the antioxidant benefit intact19.
Function studies find something. A 2007 trial in the European Heart Journal put 16 healthy women through flow-mediated dilation, an ultrasound measure of how well an artery widens, taken two hours after a cup: black tea improved it against water, and milk completely blunted the effect20, which the authors attributed to caseins forming complexes with tea catechins. A 2018 randomised crossover in 17 volunteers, four weeks per treatment, found the same direction: black tea raised that measure by 1.00 percent against hot water, milk tea lowered it against both21, and milk tea also raised systolic pressure by 1.1 mmHg and diastolic by 2.0 mmHg where plain black tea moved neither.
A widening artery two hours after a cup is a surrogate marker. Deaths over eleven years are not, and the hard outcomes come from a milk-drinking population. In the UK Biobank cohort the inverse mortality association held among those adding milk, and held across intake levels among them where the non-milk group showed no association above four to five cups. A 2023 analysis of 498,621 Biobank participants and 21,202 acute kidney injury events22 found risk turning back up at high intake for tea taken without milk, and no such upturn with it: adding milk removed the high-intake risk rather than adding one.
Milk blunts a short-term vascular marker in two trials of 16 and 17 healthy people, with no meta-analysis behind them. There is no evidence it erases the population-level benefit, and the largest cohort evidence was collected where the milk goes in. The funding cuts both ways: the absorption studies finding no effect lean industry, the function studies finding a blunted marker are academic.
The ceilings on a day's drinking
EFSA holds that intakes up to 400 mg a day, spread through the day, do not raise safety concerns10 for healthy adults, with single doses up to 200 mg likewise and 200 mg a day the figure in pregnancy. EFSA's own reference figure is 50 mg of caffeine in a 220 ml cup of black tea, which puts 400 mg at eight such cups. The FDA cites the same 400 mg for most adults11 and tabulates black tea at 71 mg per 12 fluid ounces, roughly 44 mg per 220 ml. Both are reference values, and neither is a measurement of Assam. What Assam actually carries, by grade and by processing, is measured at Assam tea and caffeine.
The IARC Monographs classed drinking very hot beverages above 65 degrees C (about 150 degrees F) as probably carcinogenic to humans, Group 2A12, for squamous cell carcinoma of the oesophagus, on limited evidence in humans and limited evidence in animals. Read that precisely: the finding is about temperature and not about tea, and it applies as readily to hot water.
A narrative review of oxalate nephropathy in Clinical Kidney Journal tabulates black iced tea among the dietary causes13, on a single case report of sixteen 8 oz glasses daily with a daily oxalate intake above 1,500 mg, and mentions another case of ten cups a day. Case reports sit at the bottom of the evidence hierarchy and describe one person each, and the review cautions that oxalate content varies broadly by measurement method, preparation and cultivar. No trial exists: extreme daily intakes have been implicated in individual cases, and ordinary drinking has not.
One ceiling is not about the leaf at all. Fluoride in Assam is overwhelmingly a groundwater question, weighed at fluoride in the water, not the tea.
Whether anyone checks what is in the packet
The letters on a packet certify leaf size and make, which is what the grade alphabet is for. They certify nothing about residue.
Asomiya Pratidin, reporting on the state's small tea growers in 2024, put the testing capacity on the record. There is no adequate facility in Assam for the test24. It is done only at the Tocklai Tea Research Institute, which can process just 10 to 15 samples a day, so samples travel from Assam to Kolkata, results take 10 to 15 days, and a small grower pays up to 4,000 rupees (about US$48) for each one.
The hole was named from inside the industry three years earlier. In a signed 2021 column in the same paper, Pranab Kumar Sarma, a former superintending manager at Tezpur Tea Company Limited, wrote that at the moment green leaf reaches the factory, no machine has yet appeared that can check how much pesticide residue is in that tea25.
The health record in the gardens
Start with the statutory fact, which explains the structure of everything downstream. In a written answer in the Lok Sabha in December 2023, the Ministry of Labour and Employment confirmed that tea industry workers fall under the social security laws on gratuity, pension, bonus, maternity benefit and wages, but that plantation workers are not covered under the Employees' State Insurance Act, 194826. India's main contributory health insurance scheme for industrial workers does not reach the gardens, which is why the garden runs its own hospital, an obligation set out in full at the garden hospital law.
What that hospital treats is on the record from the state's own health minister. Announcing the conversion of 354 tea garden hospitals into Ayushman Arogya Mandirs, each with a government community health officer and a twelve-service package, health minister Ashok Singhal enumerated the burden in Assamese: anaemia and malnutrition, high rates of maternal and newborn mortality, non-communicable disease such as high blood pressure and diabetes, and communicable disease including TB, leprosy and diarrhoea, all seen at higher rates in the state's tea garden areas27. The women's half of the record, reviewed sociologically, is weighed at the tea garden women's health gap.
A study of four named gardens, Greenwood, Maijan, Bokel and Chabua, combined population 20,903, measured chronic pulmonary aspergillosis at 60 per 100,000 against a reported global 42 per 100,00023. The team attributed it to tuberculosis, which scars the lungs the fungus then colonises. The lead researcher, Dr Rima Nath of Assam Medical College in Dibrugarh, rejected a pesticide link28 and cautioned that the tea-garden concentration partly reflects where the study looked, since lung disease is not confined to the gardens.
Uttarbanga Sambad reports that in the union budget for the 2021 to 2022 financial year the finance minister announced 10 billion rupees (about US$137 million) for the development of women and children in the tea gardens of Assam and North Bengal29, of which 6.84 billion rupees (about US$94 million) went to Assam, funding mobile medical units and door-to-door checks in gardens including Jutlibari and Moran.
A trial at Assam Medical College and Hospital used tea as a delivery vehicle: it gave 60 women a daily cup brewed from 2 g of CTC tea for 90 days30, half plain and half fortified with folate and B12, in a group where 89 percent had low folate status and 72 percent low B12. The plain CTC arm barely moved either marker: serum folate up 1.3 ng/mL, B12 up 1 pg/mL, both clinically insignificant.
Despite borderline low normal iron status in most of the women, the tea, consumed about two hours away from meals, showed no adverse effect on transferrin saturation or on haemoglobin, the measures of how much iron the blood is carrying. The full interaction between tea tannins and iron, and the anaemia record in the gardens, is set out at tannins, iron and anaemia.